187 related articles for article (PubMed ID: 26107686)
1. GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers.
Lee J; Jeong S; Lee CR; Ku CR; Kang SW; Jeong JJ; Nam KH; Shin DY; Chung WY; Lee EJ; Jo YS
Medicine (Baltimore); 2015 Jun; 94(25):e998. PubMed ID: 26107686
[TBL] [Abstract][Full Text] [Related]
2. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of Shh/Gli-1 in papillary thyroid carcinoma.
Bian XH; Sun H; Xue H; Zhang G; Zhang CH; Liu XL; Su J; Li SJ
Tumour Biol; 2014 Oct; 35(10):10523-8. PubMed ID: 25060182
[TBL] [Abstract][Full Text] [Related]
4. A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinoma.
Lee J; Seol MY; Jeong S; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
Medicine (Baltimore); 2015 Jan; 94(2):e380. PubMed ID: 25590838
[TBL] [Abstract][Full Text] [Related]
5. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
Yue C; Zhao X; Tian C; Jin Y; Liu H
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):490-4. PubMed ID: 26705040
[TBL] [Abstract][Full Text] [Related]
6. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
[TBL] [Abstract][Full Text] [Related]
7. Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer.
Kim JR; Kim BH; Kim SM; Oh MY; Kim WJ; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ
Thyroid; 2014 Nov; 24(11):1618-24. PubMed ID: 25133449
[TBL] [Abstract][Full Text] [Related]
8. Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer.
Jeong S; Lee J; Kim D; Seol MY; Lee WK; Jeong JJ; Nam KH; Jung SG; Shin DY; Lee EJ; Chung WY; Jo YS
Medicine (Baltimore); 2016 Jan; 95(4):e2592. PubMed ID: 26825907
[TBL] [Abstract][Full Text] [Related]
9. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of COT is related to recurrence of papillary thyroid cancer.
Lee J; Jeong S; Park JH; Lee CR; Ku CR; Kang SW; Jeong JJ; Nam KH; Shin DY; Lee EJ; Chung WY; Jo YS
Medicine (Baltimore); 2015 Feb; 94(6):e548. PubMed ID: 25674762
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation.
Xu X; Ding H; Rao G; Arora S; Saclarides CP; Esparaz J; Gattuso P; Solorzano CC; Prinz RA
Endocr Relat Cancer; 2012 Apr; 19(2):167-79. PubMed ID: 22241722
[TBL] [Abstract][Full Text] [Related]
12. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
13. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.
Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ
Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160
[TBL] [Abstract][Full Text] [Related]
14. Quantitative shear wave elastography as a prognostic implication of papillary thyroid carcinoma (PTC): elasticity index can predict extrathyroidal extension (ETE).
Park YJ; Kim JA; Son EJ; Youk JH; Park CS
Ann Surg Oncol; 2013 Aug; 20(8):2765-71. PubMed ID: 23463092
[TBL] [Abstract][Full Text] [Related]
15. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
16. Role of BRAF and RAS Mutations in Extrathyroidal Extension in Papillary Thyroid Cancer.
Park JY; Yi JW; Park CH; Lim Y; Lee KH; Lee KE; Kim JH
Cancer Genomics Proteomics; 2016; 13(2):171-81. PubMed ID: 26912807
[TBL] [Abstract][Full Text] [Related]
17. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract][Full Text] [Related]
18. KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer.
Lee J; Seol MY; Jeong S; Kwon HJ; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
J Mol Endocrinol; 2015 Apr; 54(2):115-24. PubMed ID: 25608512
[TBL] [Abstract][Full Text] [Related]
19. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
[TBL] [Abstract][Full Text] [Related]
20. The relationship between subclinical hypothyroidism and invasive papillary thyroid cancer.
Li C; Zhang J; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1294441. PubMed ID: 38174330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
